Explore
Validate
LearnABIN396093
antibody from antibodies-online
Targeting: ABCC8
ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396093 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-ATP-Binding Cassette, Sub-Family C (CFTR/MRP), Member 8 (ABCC8) antibody
- Antibody type
- Monoclonal
- Antigen
- ABCC8 (NP_000343, 611 a.a. ~ 711 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 3G5
- Vial size
- 0.05 mg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
A Large-scale genetic association study of esophageal adenocarcinoma risk.
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.
Jablonski KA, McAteer JB, de Bakker PI, Franks PW, Pollin TI, Hanson RL, Saxena R, Fowler S, Shuldiner AR, Knowler WC, Altshuler D, Florez JC, Diabetes Prevention Program Research Group
Diabetes 2010 Oct;59(10):2672-81
Diabetes 2010 Oct;59(10):2672-81
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
A Large-scale genetic association study of esophageal adenocarcinoma risk.
Liu CY, Wu MC, Chen F, Ter-Minassian M, Asomaning K, Zhai R, Wang Z, Su L, Heist RS, Kulke MH, Lin X, Liu G, Christiani DC
Carcinogenesis 2010 Jul;31(7):1259-63
Carcinogenesis 2010 Jul;31(7):1259-63
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Ruaño G, Thompson PD, Kane JP, Pullinger CR, Windemuth A, Seip RL, Kocherla M, Holford TR, Wu AH
Pharmacogenomics 2010 Jul;11(7):959-71
Pharmacogenomics 2010 Jul;11(7):959-71
Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.
Ruchat SM, Vohl MC, Weisnagel SJ, Rankinen T, Bouchard C, Pérusse L
Annals of medicine 2010 Apr;42(3):196-206
Annals of medicine 2010 Apr;42(3):196-206
No comments: Submit comment
No validations: Submit validation data